Advisors Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.4M | Sell |
10,767
-3,812
| -26% | -$1.83M | 0.08% | 325 |
|
|
2026
Q1 | $7.17M | Buy |
14,579
+228
| +2% | +$124K | 0.12% | 230 |
|
|
2025
Q4 | $8.32M | Sell |
14,351
-3,230
| -18% | -$1.83M | 0.14% | 179 |
|
|
2025
Q3 | $8.53M | Sell |
17,581
-1,871
| -10% | -$871K | 0.14% | 167 |
|
|
2025
Q2 | $7.89M | Sell |
19,452
-1,579
| -8% | -$660K | 0.14% | 173 |
|
|
2025
Q1 | $10.5M | Buy |
21,031
+419
| +2% | +$227K | 0.2% | 112 |
|
|
2024
Q4 | $10.7M | Sell |
20,612
-1,091
| -5% | -$600K | 0.2% | 109 |
|
|
2024
Q3 | $13.4M | Buy |
21,703
+1,179
| +6% | +$698K | 0.25% | 79 |
|
|
2024
Q2 | $11.3M | Buy |
20,524
+236
| +1% | +$135K | 0.22% | 88 |
|
|
2024
Q1 | $11.8M | Buy |
20,288
+1,319
| +7% | +$740K | 0.23% | 92 |
|
|
2023
Q4 | $10.1M | Sell |
18,969
-1,987
| -9% | -$962K | 0.2% | 112 |
|
|
2023
Q3 | $10.6M | Sell |
20,956
-155
| -0.7% | -$82.6K | 0.23% | 88 |
|
|
2023
Q2 | $11M | Sell |
21,111
-3,312
| -14% | -$1.79M | 0.22% | 92 |
|
|
2023
Q1 | $14.1M | Sell |
24,423
-4,866
| -17% | -$2.74M | 0.28% | 62 |
|
|
2022
Q4 | $16.1M | Sell |
29,289
-6,926
| -19% | -$3.67M | 0.33% | 55 |
|
|
2022
Q3 | $18.4M | Sell |
36,215
-3,700
| -9% | -$2.07M | 0.36% | 49 |
|
|
2022
Q2 | $21.7M | Sell |
39,915
-3,432
| -8% | -$1.89M | 0.39% | 44 |
|
|
2022
Q1 | $25.6M | Sell |
43,347
-870
| -2% | -$500K | 0.39% | 44 |
|
|
2021
Q4 | $29.5M | Sell |
44,217
-152
| -0.3% | -$94.9K | 0.42% | 36 |
|
|
2021
Q3 | $25.3M | Sell |
44,369
-7,438
| -14% | -$4.08M | 0.38% | 38 |
|
|
2021
Q2 | $26.1M | Sell |
51,807
-2,800
| -5% | -$1.32M | 0.37% | 45 |
|
|
2021
Q1 | $24.9M | Sell |
54,607
-8,039
| -13% | -$3.84M | 0.39% | 37 |
|
|
2020
Q4 | $29.2M | Sell |
62,646
-4,406
| -7% | -$2.07M | 0.46% | 32 |
|
|
2020
Q3 | $29.6M | Sell |
67,052
-232
| -0.3% | -$95.8K | 0.55% | 28 |
|
|
2020
Q2 | $24.4M | Buy |
67,284
+2,063
| +3% | +$691K | 0.47% | 30 |
|
|
2020
Q1 | $18.5M | Sell |
65,221
-4,212
| -6% | -$1.33M | 0.43% | 35 |
|
|
2019
Q4 | $22.6M | Sell |
69,433
-4,753
| -6% | -$1.44M | 0.4% | 40 |
|
|
2019
Q3 | $21.6M | Sell |
74,186
-8,334
| -10% | -$2.39M | 0.4% | 44 |
|
|
2019
Q2 | $24.2M | Sell |
82,520
-4,015
| -5% | -$1.11M | 0.43% | 36 |
|
|
2019
Q1 | $23.7M | Sell |
86,535
-6,235
| -7% | -$1.55M | 0.43% | 40 |
|
|
2018
Q4 | $20.8M | Sell |
92,770
-5,514
| -6% | -$1.29M | 0.42% | 44 |
|
|
2018
Q3 | $24M | Buy |
98,284
+4,463
| +5% | +$1.03M | 0.39% | 42 |
|
|
2018
Q2 | $19.4M | Buy |
93,821
+9,832
| +12% | +$2.09M | 0.33% | 61 |
|
|
2018
Q1 | $17.5M | Buy |
83,989
+7,571
| +10% | +$1.59M | 0.29% | 78 |
|
|
2017
Q4 | $14.5M | Buy |
76,418
+4,367
| +6% | +$837K | 0.24% | 104 |
|
|
2017
Q3 | $13.6M | Buy |
72,051
+7,717
| +12% | +$1.4M | 0.23% | 104 |
|
|
2017
Q2 | $11.2M | Sell |
64,334
-1,974
| -3% | -$332K | 0.19% | 131 |
|
|
2017
Q1 | $10.2M | Buy |
66,308
+735
| +1% | +$112K | 0.17% | 156 |
|
|
2016
Q4 | $9.25M | Buy |
65,573
+4,978
| +8% | +$734K | 0.15% | 180 |
|
|
2016
Q3 | $9.64M | Sell |
60,595
-1,336
| -2% | -$206K | 0.16% | 183 |
|
|
2016
Q2 | $9.15M | Buy |
61,931
+6,443
| +12% | +$951K | 0.15% | 197 |
|
|
2016
Q1 | $7.86M | Sell |
55,488
-10,579
| -16% | -$1.42M | 0.13% | 231 |
|
|
2015
Q4 | $9.37M | Buy |
66,067
+865
| +1% | +$115K | 0.15% | 196 |
|
|
2015
Q3 | $7.97M | Buy |
65,202
+6,477
| +11% | +$844K | 0.13% | 228 |
|
|
2015
Q2 | $7.62M | Buy |
58,725
+5,667
| +11% | +$739K | 0.1% | 264 |
|
|
2015
Q1 | $7.13M | Sell |
53,058
-7,889
| -13% | -$1.02M | 0.09% | 271 |
|
|
2014
Q4 | $7.64M | Sell |
60,947
-889
| -1% | -$108K | 0.1% | 251 |
|
|
2014
Q3 | $7.53M | Buy |
61,836
+1,809
| +3% | +$220K | 0.1% | 247 |
|
|
2014
Q2 | $7.08M | Buy |
60,027
+7,223
| +14% | +$850K | 0.1% | 253 |
|
|
2014
Q1 | $6.35M | Buy |
52,804
+14,470
| +38% | +$1.72M | 0.1% | 265 |
|
|
2013
Q4 | $4.27M | Buy |
38,334
+15,523
| +68% | +$1.54M | 0.07% | 349 |
|
|
2013
Q3 | $2.1M | Buy |
22,811
+3,180
| +16% | +$288K | 0.04% | 472 |
|
|
2013
Q2 | $1.66M | Buy |
+19,631
| New | +$1.63M | 0.03% | 507 |
|
Other funds holding TMO
Advisors Asset Management's TMO Position: Q2 2026 in Review
Advisors Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, selling an estimated $1.83M and leaving 10,767 shares worth $5.4M. The position accounts for 0.08% of the portfolio, ranked #325.
Advisors Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.6M in Q3 2020. 2,621 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Advisors Asset Management held 10,767 shares of Thermo Fisher Scientific worth $5.4M as of Q2 2026.
- Advisors Asset Management sold 3,812 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.83M.
- Thermo Fisher Scientific made up 0.08% of Advisors Asset Management's portfolio in Q2 2026, its #325 holding.
- Advisors Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Advisors Asset Management's Thermo Fisher Scientific position peaked at $29.6M in Q3 2020.
- 2,621 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.